Improvement of nebulised antibiotic delivery in cystic fibrosis

Area of Science:

• Pulmonary Medicine
• Pediatric Respiratory Care
• Medical Device Technology

Background:

• Cystic Fibrosis (CF) management often involves nebulized antibiotics for lung infections.
• Nebulizer system performance, including particle size and delivery rate, impacts drug deposition.
• Optimizing nebulizer use is crucial for effective CF treatment in children.

Purpose of the Study:

• To compare deposition patterns of nebulized antibiotics in children with CF using two different nebulizer systems.
• To assess and compare the delivery rates of the Ventstream and Optimist nebulizer systems.

Main Methods:

• Radioisotope scans using technetium-99m labeled antibiotic aerosol were performed on 33 children with CF.
• Two nebulizer systems, Ventstream (MMD 3.3 µm, 0.075 ml/min) and Optimist (MMD 1.8 µm, 0.02 ml/min), were evaluated.
• Lung deposition inhomogeneity and stomach deposition were quantified; 20 patients used both devices.

Main Results:

• The Optimist nebulizer (smaller particle size) showed significantly lower inhomogeneity scores (3.5 vs. 5.4) and reduced stomach deposition (1.6% vs. 11.8%).
• Ventstream nebulizer demonstrated a faster delivery rate, approximately 2.8 times that of the Optimist.
• A significant inverse relationship was observed between patient height and stomach deposition (r = 0.69).

Conclusions:

• Smaller nebulizer particle size leads to more homogeneous lung antibiotic distribution and less systemic absorption in CF patients.
• Despite better homogeneity, the Ventstream's higher delivery rate may result in greater overall antibiotic deposition in the lungs.
• Nebulizer choice in CF treatment should balance particle size, delivery efficiency, and desired lung deposition.